Last reviewed · How we verify

IV Iron (standard of care)

Nicoletta C Machin · Phase 3 active Small molecule

IV Iron (standard of care) is a Iron replacement therapy Small molecule drug developed by Nicoletta C Machin. It is currently in Phase 3 development for Iron deficiency anemia in patients intolerant of or unresponsive to oral iron, Iron deficiency anemia in chronic kidney disease patients on hemodialysis, Perioperative iron replacement.

IV iron replenishes depleted iron stores by delivering iron directly into the bloodstream for incorporation into hemoglobin and other iron-dependent proteins.

IV iron replenishes depleted iron stores by delivering iron directly into the bloodstream for incorporation into hemoglobin and other iron-dependent proteins. Used for Iron deficiency anemia in patients intolerant of or unresponsive to oral iron, Iron deficiency anemia in chronic kidney disease patients on hemodialysis, Perioperative iron replacement.

At a glance

Generic nameIV Iron (standard of care)
SponsorNicoletta C Machin
Drug classIron replacement therapy
ModalitySmall molecule
Therapeutic areaHematology
PhasePhase 3

Mechanism of action

Intravenous iron formulations bypass gastrointestinal absorption limitations and rapidly restore systemic iron levels in patients with iron deficiency anemia. The iron is transported to bone marrow erythroid precursors and other tissues where it is incorporated into hemoglobin, myoglobin, and iron-dependent enzymes, restoring oxygen-carrying capacity and metabolic function.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about IV Iron (standard of care)

What is IV Iron (standard of care)?

IV Iron (standard of care) is a Iron replacement therapy drug developed by Nicoletta C Machin, indicated for Iron deficiency anemia in patients intolerant of or unresponsive to oral iron, Iron deficiency anemia in chronic kidney disease patients on hemodialysis, Perioperative iron replacement.

How does IV Iron (standard of care) work?

IV iron replenishes depleted iron stores by delivering iron directly into the bloodstream for incorporation into hemoglobin and other iron-dependent proteins.

What is IV Iron (standard of care) used for?

IV Iron (standard of care) is indicated for Iron deficiency anemia in patients intolerant of or unresponsive to oral iron, Iron deficiency anemia in chronic kidney disease patients on hemodialysis, Perioperative iron replacement.

Who makes IV Iron (standard of care)?

IV Iron (standard of care) is developed by Nicoletta C Machin (see full Nicoletta C Machin pipeline at /company/nicoletta-c-machin).

What drug class is IV Iron (standard of care) in?

IV Iron (standard of care) belongs to the Iron replacement therapy class. See all Iron replacement therapy drugs at /class/iron-replacement-therapy.

What development phase is IV Iron (standard of care) in?

IV Iron (standard of care) is in Phase 3.

What are the side effects of IV Iron (standard of care)?

Common side effects of IV Iron (standard of care) include Injection site reactions (pain, discoloration), Headache, Nausea, Hypersensitivity reactions, Dizziness.

Related